Innovative technique to reduce incidence of Frey's syndrome after parotid surgery
- PMID: 21375851
Innovative technique to reduce incidence of Frey's syndrome after parotid surgery
Abstract
Frey's syndrome was first described by Lucia Frey, a Polish neurologist in 1923. It is well accepted that it involves injury to the branches of the auriculotemporal nerve with subsequent aberrant regeneration. Due to this abnormal communication, the skin glands and vessels are always stimulated at the same time as eating and mastication, which results in symptoms such as flushing and sweating. The incidence of Frey's syndrome in the literature has been variously described from 6 to 96 per cent. We analyzed the chart of 18 patients who had parotidectomy from March 2002 to December 2009. All procedures were performed by a single surgeon at the same facility. A total of 16 superficial and three total parotidectomies were done; one patient had bilateral parotidectomy. Oxidized regenerated cellulose (Interceed) was used after 10 surgeries (study group) and no adjuvant was used after nine surgeries (control group). All of the surgeries were done using similar technique. All the patients were followed-up with for a period of about 6 months postoperatively. The absolute risk reduction associated with the placement of an Interceed was 11 per cent. The small number of cases (n = 19) and an empty cell limits statistical analysis (a Fisher's exact test revealed a P value of 0.44). Clearly the low number of procedures restricted the power to test these differences. The development of Frey's syndrome is a very disabling but under-reported complication. The placement of a temporary barrier like Interceed may help in the prevention of Frey's syndrome without increasing any complications.
Similar articles
-
Risk of facial palsy and severe Frey's syndrome after conservative parotidectomy for benign disease: analysis of 610 operations.Acta Otolaryngol. 2006 Oct;126(10):1104-9. doi: 10.1080/00016480600672618. Acta Otolaryngol. 2006. PMID: 16923718
-
The use of acellular dermis in the prevention of Frey's syndrome.Laryngoscope. 2001 Nov;111(11 Pt 1):1993-8. doi: 10.1097/00005537-200111000-00024. Laryngoscope. 2001. PMID: 11801985 Clinical Trial.
-
Use of allogenic acellular dermal matrix in prevention of Frey's syndrome after parotidectomy.Br J Oral Maxillofac Surg. 2008 Dec;46(8):649-52. doi: 10.1016/j.bjoms.2007.11.006. Epub 2008 Jun 10. Br J Oral Maxillofac Surg. 2008. PMID: 18547692 Clinical Trial.
-
[Contribution of L lactate and amino-acid enzymatic biosensors for the analysis of Frey syndrome].Ann Otolaryngol Chir Cervicofac. 1994;111(6):347-52. Ann Otolaryngol Chir Cervicofac. 1994. PMID: 7785935 Review. French.
-
Treatment of complications of parotid gland surgery.Acta Otorhinolaryngol Ital. 2005 Jun;25(3):174-8. Acta Otorhinolaryngol Ital. 2005. PMID: 16450773 Free PMC article. Review.
Cited by
-
Graft interposition for preventing Frey's syndrome in patients undergoing parotidectomy.Cochrane Database Syst Rev. 2019 Oct 3;10(10):CD012323. doi: 10.1002/14651858.CD012323.pub2. Cochrane Database Syst Rev. 2019. PMID: 31578708 Free PMC article. Review.
-
Botulinum toxin therapy: functional silencing of salivary disorders.Acta Otorhinolaryngol Ital. 2017 Apr;37(2):168-171. doi: 10.14639/0392-100X-1608. Acta Otorhinolaryngol Ital. 2017. PMID: 28516981 Free PMC article. Review.
-
Interventions for the treatment of Frey's syndrome.Cochrane Database Syst Rev. 2015 Mar 17;2015(3):CD009959. doi: 10.1002/14651858.CD009959.pub2. Cochrane Database Syst Rev. 2015. PMID: 25781421 Free PMC article.
-
Frey's Syndrome: A Review of Aetiology and Treatment.Cureus. 2021 Dec 2;13(12):e20107. doi: 10.7759/cureus.20107. eCollection 2021 Dec. Cureus. 2021. PMID: 34873562 Free PMC article. Review.